We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 720.00
Bid: 721.00
Ask: 726.00
Change: 0.00 (0.00%)
Spread: 5.00 (0.693%)
Open: 695.00
High: 736.00
Low: 695.00
Prev. Close: 720.00
DSCV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Annual General Meeting

24 Jul 2023 14:31

RNS Number : 9978G
discoverIE Group plc
24 July 2023
 

 

24 July 2023

 

discoverIE Group plc

 

Results of Annual General Meeting

 

discoverIE Group plc (LSE: DSCV, "discoverIE" or "The Group"), a leading international designer and manufacturer of customised electronics for industrial applications, announces that, at the Annual General Meeting held earlier today, all resolutions were approved. The following levels of proxy votes were received:

 

Resolution

 

Votes For

Votes Against

Withheld

1

Receipt and Adoption of

Financial Statements

79,915,512

99.84%

128,594

0.16%

289,221

2

Approval of Final Dividend

80,326,665

99.99%

5,434

0.01%

1,228

3

Approval of Directors'

Remuneration Report

79,145,375

98.53%

1,180,225

1.47%

7,727

4

Re-election of Bruce Thompson

78,008,388

97.11%

2,323,111

2.89%

1,828

5

Re-election of Nick Jefferies

77,226,472

96.14%

3,104,552

3.86%

2,303

6

Re-election of Simon Gibbins

80,269,676

99.92%

61,348

0.08%

2,303

7

Re-election of Tracey Graham

78,539,531

97.77%

1,791,968

2.23%

1,828

8

Re-election of Clive Watson

73,430,161

97.79%

1,657,063

2.21%

5,246,103

9

Re-election of Rosalind Kainyah

78,538,027

98.06%

1,555,472

1.94%

239,828

10

Election of Celia Baxter

80,294,388

99.95%

37,111

0.05%

1,828

11

Re-appointment of Auditor

80,087,413

99.70%

241,001

0.30%

4,913

12

Authority to fix Auditor's Remuneration

80,325,414

100.00%

3,000

0.00%

4,913

13

Authority to Allot Shares

68,888,988

86.01%

11,205,111

13.99%

239,228

14

Additional Authority to Allot Shares

68,539,754

85.32%

11,792,345

14.68%

1,228

15

Authority to Disapply Statutory

Pre-Emption Rights

76,425,833

95.14%

3,906,266

4.86%

1,228

16

Additional Authority to Disapply Statutory Pre-Emption Rights (acquisition or specified capital investment)

73,333,491

93.22%

5,332,087

6.78%

1,667,749

17

Additional Authority to Allot Shares

68,298,376

85.02%

12,033,025

14.98%

1,926

18

Authority to Purchase Company's Own Shares

79,205,735

99.70%

238,000

0.30%

889,592

19

Notice of General Meetings

76,552,647

95.30%

3,779,452

4.70%

1,228

20

To authorise political donations

78,320,947

98.11%

1,508,490

1.89%

502,667

 

As at today's date discoverIE Group plc has 95,456,109 ordinary shares in issue.

A copy of the resolutions approved by Shareholders will be placed on the National Storage Mechanism.

 

 

For further information, please contact:

 

discoverIE Group plc

Greg Davidson - Company Secretary 01483 544 500

 

 

Buchanan

Chris Lane, Toto Berger, Jack Devoy 020 7466 5000

discoverIE@buchanan.uk.com

 

 

 

Notes to Editors:

 

discoverIE Group plc is an international group of businesses that designs and manufactures innovative electronic components for industrial applications.

 

The Group provides application-specific components to original equipment manufacturers ("OEMs") internationally through its two divisions, Magnetics & Controls, and Sensing & Connectivity. By designing components that meet customers' unique requirements, which are then manufactured and supplied throughout the life of their production, a high level of repeating revenue is generated with long term customer relationships.

 

With a focus on sustainable key markets driven by structural growth and increasing electronic content, namely renewable energy, medical, electrification of transportation and industrial automation & connectivity, the Group aims to achieve organic growth that is well ahead of GDP and to supplement that with complementary acquisitions. The Group has an ongoing commitment to reducing the impact of its operations on the environment and with its key markets aligned with a sustainable future, MSCI has awarded the Group an ESG "A" rating. 

 

The Group employs c.5,000 people across 20 countries with its principal operating units located in Continental Europe, the UK, China, Sri Lanka, India and North America.

 

discoverIE is listed on the Main Market of the London Stock Exchange and is a member of the FTSE250, classified within the Electrical Components and Equipment subsector.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSESFDLEDSEDW
Date   Source Headline
18th Apr 20247:00 amRNSFull Year Trading Update
28th Mar 20247:30 amRNSDirector Declaration
22nd Mar 20248:09 amRNSNotification of Major Holdings
20th Mar 20243:45 pmRNSDirector/PDMR Shareholding
14th Mar 20241:21 pmRNSDirector/PDMR Shareholding
19th Feb 20244:07 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSTrading Update
29th Jan 202410:31 amRNSDirector / PDMR Shareholding
8th Jan 20248:41 amRNSNotification of Major Holdings
4th Jan 20244:03 pmRNSNotification of Major Holdings
21st Dec 20233:57 pmRNSNotification of Major Holdings
13th Dec 20239:03 amRNSNotification of Major Holdings
8th Dec 202310:52 amRNSNotification of Major Holdings
5th Dec 20237:00 amRNSInterim Results
22nd Nov 20238:30 amRNSNotice of Interim Results
11th Oct 20237:00 amRNSFirst Half Trading Update
15th Sep 20239:11 amRNSDirector/PDMR Shareholding
13th Sep 20237:00 amRNSAcquisition of 2J Antennas Group
5th Sep 20232:17 pmRNSNotification of Major Holdings
31st Aug 20237:00 amRNSAcquisition completion - Silvertel
1st Aug 20237:00 amRNSAcquisition of Silvertel
24th Jul 20232:31 pmRNSResults of Annual General Meeting
24th Jul 20237:00 amRNSTrading Update
27th Jun 202310:53 amRNSDirector / PDMR Shareholding
27th Jun 202310:47 amRNSNotification of Major Holdings
22nd Jun 202312:35 pmRNSAnnual Report & Notice of AGM
19th Jun 20238:35 amRNSNotification of Major Holdings
15th Jun 20239:51 amRNSDirector LTIP Award
7th Jun 20237:00 amRNSPreliminary results
1st Jun 20232:50 pmRNSNotification of Major Holdings
30th May 20237:00 amRNSAppointment of Non-Executive Director
18th May 20231:33 pmRNSNotification of Major Holdings
17th May 202310:25 amRNSNotice of Full Year Results
19th Apr 20237:00 amRNSFull Year Trading Update
18th Apr 20237:00 amRNSNotification of Major Holdings
29th Mar 20235:47 pmRNSNotification of Major Holdings
15th Mar 20233:53 pmRNSNotification of Major Holdings
15th Mar 20238:37 amRNSNotification of Major Holdings
15th Mar 20237:00 amRNSNotification of Major Holdings
23rd Feb 20232:58 pmRNSNotification of Major Holdings
20th Feb 20239:48 amRNSNotification of Major Holdings
15th Feb 20235:33 pmRNSNotification of Major Holdings
13th Feb 202311:36 amRNSNotification of Major Holdings
25th Jan 20237:00 amRNSQ3 Trading Update and Acquisition Completion
6th Jan 20231:41 pmRNSNotification of Major Holdings
6th Jan 20238:24 amRNSNotification of Major Holdings
3rd Jan 202310:38 amRNSNotification of Major Holdings
22nd Dec 20227:00 amRNSAcquisition of Magnasphere Corporation
14th Dec 20224:31 pmEQSParadigm Biopharmaceuticals (PAR): Adapted therapies to meet unmet demand
5th Dec 20229:53 amEQSdiscoverIE Group (DSCV): Focused on sustainable growth

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.